Mammalian parthenogenetic embryos (pE) are not viable due to placental deficiency, presumably resulting from lack of paternally expressed imprinted genes. Pluripotent parthenogenetic embryonic stem (pES) cells derived from pE could advance regenerative medicine by avoiding immuno-rejection and ethical roadblocks. We attempted to explore the epigenetic status of imprinted genes in the generation of pES cells from parthenogenetic blastocysts, and its relationship to pluripotency of pES cells. Pluripotency was evaluated for developmental and differentiation potential in vivo, based on contributions of pES cells to chimeras and development to day 9.5 of pES fetuses complemented by tetraploid embryos (TEC). Consistently, pE and fetuses failed to express paternally expressed imprinted genes, but pES cells expressed those genes in a pattern resembling that of fertilized embryos (fE) and fertilized embryonic stem (fES) cells derived from fE. Like fE and fES cells, but unlike pE or fetuses, pES cells and pES cell -fetuses complemented by TEC exhibited balanced methylation of Snrpn, Peg1 and U2af1-rs1. Coincidently, global methylation increased in pE but decreased in pES cells, further suggesting dramatic epigenetic reprogramming occurred during isolation and culture of pES cells. Moreover, we identified decreased methylation of Igf2r, Snrpn, and especially U2af1-rs1, in association with increased contributions of pES cells to chimeras. Our data show that in vitro culture changes epigenetic status of imprinted genes during isolation of pES cells from their progenitor embryos and that increased expression of U2af1-rs1 and Snrpn and decreased expression of Igf2r correlate with pluripotency of pES cells.
INTRODUCTION
Embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass (ICM) of blastocysts. ES cells can proliferate indefinitely in vitro and can differentiate into a wide variety of cell types both in vivo and in vitro (1, 2) . Human ES cells hold promise in the treatment of degenerative disorders such as Parkinsons, Alzheimers and diabetes mellitus (3) . However, human ES cells derived from spare, fertilized embryos (fE) from fertility clinics will inevitably be genetically divergent from the patients requiring tissue transplantation, and, as such, will incite an immune response, resulting in rejection unless an immunosuppression regimen is employed. This has prompted a search for alternative sources of histocompatible, pluripotent stem cells. Parthenogenetic ES (pES) cells represent one potential source of stem cells which would be histocompatible with the oocyte donor (4) . Diploid parthenotes are incapable of full-term development and typically die at mid-gestation (5) . In mammals, viable offspring have not been produced from parthenotes without genetic manipulation (6) . The limited developmental potential of parthenotes should obviate concerns about the destruction of potential human life, and thus bypass most ethical concerns regarding derivation of human ES cells (7) . PES cells have been isolated from parthenogenetic blastocysts of mice (8, 9) , rabbits (10, 11) , non-human primates (12, 13) and humans (14 -17) . Although parthenogenetic embryos (pE) lack full-term developmental potential because they are deficient in the expression of key paternal alleles, pES cells isolated from pE show extensive differentiation in vitro and can contribute to chimeric mice in vivo (18) . Yet, efficacy and safety issues currently limit the use of pES cells in regenerative medicine, presumably due to the consequences of aberrant genomic imprinting (19, 20) . To date, more than 80 imprinted genes and transcripts have been identified in mice and humans. Imprinted genes represent a small subset of mammalian genes that are monoallelically expressed in a parent-of-origin manner (either the paternal or maternal allele). Imprints are established during gametogenesis and play important roles in fetal growth and development (21) . Aberrant allele-specific expression of imprinted genes disrupts fetal development, and is associated with genetic diseases, some cancers and a number of neurological disorders (22 -24) . The establishment of genomic imprinting is controlled by DNA methylation, histone modifications, non-coding RNA's and specialized chromatin structure. Allele-specific DNA methylation is thought to be a major factor regulating genomic imprinting. Specific DNA methylation in the differentially methylated regions (DMRs) of parental origin allows the discrimination between paternal and maternal alleles and leads to monoallelic expression of imprinted genes (25, 26) .
Although stem cells from mouse homozygous embryos have been established and studied since 1983 (27) , controversies persist regarding the pluripotency of pES cells. Previously, pES cells derived from oocytes activated by 6-7% ethanol showed limited pluripotency and exhibited strong tissue preference with limited or no contribution to muscles and gonads in chimeric mice (18, 28, 29) . Activation with 6 -7% ethanol generates only a single rise in cytoplasmic Ca 2þ , in contrast to the Ca 2þ oscillations induced by fertilization of sperm, which fully activate oocytes (30) (31) (32) . Moreover, suboptimal culture medium could cause aberrant genomic imprinting and embryo development, whereas embryos cultured in potassium simplex optimized medium added with amino acid (KSOM AA ) show global gene expression, genomic imprinting and embryo development resembling in vivo developed embryos (33, 34) . By mimicking sperminduced Ca 2þ oscillations, strontium (Sr 2þ ) fully activates oocytes (35) , leading to pre-implantation embryo development that is indistinguishable from fE cultured in KSOM AA (36, 37) . We have produced pES cell lines from parthenogenetic blastocysts obtained from the activation of oocytes by Sr 2þ and cultured in KSOM AA . The developmental competence of these pES cells is comparable to fES cell lines, as evidenced by high rates of chimera production and germline transmission.
How the pluripotency of pES cells relates to the expression and methylation of imprinted genes, however, has not been fully explored. In this study, we utilized several new pluripotent mouse pES cell lines (C2, C3 and 1116) derived by activation with Sr 2þ to analyze gene expression and methylation in pES cells and in pES cell -fetuses supported by tetraploid embryos (TEC), which provide placenta for development, and compared these with early pE and fetuses, fE, fertilized ES (fES) cells and fES cell -fetuses supported by TEC. We further attempted to correlate methylation of imprinted genes with developmental potential in vivo, as shown by the contribution of pES cells to chimeras.
RESULTS

Epigenetic regulation of imprinted genes during isolation and culture of mouse PES cells
RT-PCR analysis showed that paternally expressed imprinted genes, except for Peg3, Igf2, U2af1-rs1, Dlk1, Air and Impact, were silenced in parthenogenetic blastocysts, but activated in pES cells and pES cell -fetuses supported by TEC, except for that expression of Igf2 and Dlk1 remained deficient in pES cell -fetuses supported by TEC (Fig. 1A) . Fetuses derived from pES cells were distinguished from TEC by microsatellite analysis (Supplementary Material, Fig. S1 ). Maternally expressed imprinted genes remained activated in parthenogenetic blastocysts, pES cells and pES cell -fetuses from TEC (Fig. 1A) . When pES cell lines (B6C3F1 -C2, B6C3F1 -C3, B6C3F1 -1116) were compared with fES cell lines (B6C3F1 -F1, B6C3F1-F5, B6C3F1 -FT), they were found to produce similar results in the gene expression in at least three repeated experiments.
Methylation analysis by combined bisulfite restriction analysis (COBRA) showed that methylation of the imprinted control region (ICR) of Igf2/H19 and intergenic DMR of Dlk1/Gtl2 was similar in parthenogenetic blastocysts, pES cells and pES cell -fetuses supported by TEC, maintaining the unmethylated status of maternal alleles (Fig. 1B) . These DMRs are methylated only in paternal gametes. DMR2 of Igf2r in fertilized blastocysts at day 3.5 exhibited both unmethylated and methylated alleles. Methylation of DMR2 of Igf2r was relatively increased in parthenogenetic blastocysts, and obviously increased in day 9.5 parthenogenetic embryonic fetuses, but the methylation status in pES cells and pES cell -fetuses supported by TEC did not differ from that of fE and fES cells. Methylation status in the DMRs of Snrpn, Peg1 and U2af1-rs1 differed among parthenogenetic blastocysts, pES cells, parthenogenetic embryonic fetuses with no TEC and pES cell -fetuses supported by TEC. The DMRs were demethylated in pES cells or pES cell -fetuses supported by TEC, resembling fES cells and fE that showed both methylated and unmethylated alleles. Yet day 9.5 parthenogenetic embryonic fetuses with no TEC showed only methylated alleles for these genes (Fig. 1B) . These data suggest that the processes of isolation and in vitro culture of pES cells significantly reprogram the epigenome of paternally expressed imprinted genes.
To further quantify expression and methylation of imprinted genes in pES cells, we performed real-time PCR and bisulfite sequencing analysis. H19, Gtl2 and Igf2r exhibited remarkably higher expression (P , 0.01) in parthenogenetic blastocysts, whereas Snrpn, Peg1 and U2af1-rs1 were expressed at lower levels than in fertilized blastocysts. Expression of Igf2 and Dlk1 did not differ between parthenogenetic and fertilized blastocysts ( Fig. 2A) . To understand whether the expression of imprinted genes in blastocysts differ from the resultant ES cells, we compared expression of imprinted genes in pES (Fig. 2B) . We also compared the expression of imprinted genes in day 9.5 pES cell -fetuses supported by TEC with day 9.5 fES cell -fetuses supported by TEC and day 9.5 parthenogenetic embryonic fetuses without TEC. Consistent with a previous report (38) , day 9.5 parthenogenetic embryonic fetuses maintained expression of maternally expressed imprinted genes H19, Gtl2 and Igf2r with a two-fold increase, whereas the paternally expressed imprinted genes Snrpn, Peg1, U2af1-rs1, Igf2 and Dlk1 were silenced or reduced. However, Snrpn, Peg1 and U2af1-rs1 in pES cell -fetuses supported by TEC not only were activated, but their expression levels were close to the normal levels of fES cell -fetuses supported by TEC. Expression levels of H19, Gtl2 and Igf2r in pES cell -fetuses supported by TEC were significantly reduced, comparable to those of fES cellfetuses supported by TEC. Consistent with RT -PCR data (Fig. 1A ), Igf2 and Dlk1 still were not activated in were enzymes for detecting methylation status of Igf2/H19 ICR, Dlk1/Gtl2 IG-DMR, Igf2r DMR2, Snrpn DMR1, Peg1 promoter and exon 1, and U2af1-rs1 promoter and exon 1, respectively. Abbreviations: fE-3.5, fertilized embryos at day 3.5; pE-3.5, parthenogenetic embryos at day 3.5; fES, fertilized embryonic stem cells at passages 10; pES, parthenogenetic embryonic stem cells at passages 10; fES-TEC-9.5, fES cell -fetuses at day 9.5 supported by tetraploid embryo complementation (TEC); pE-9.5, parthenogenetic embryonic fetuses at day 9.5; pES-TEC-9.5: pES cell-fetuses at day 9.5 supported by TEC. Shown are representative images from three independent experiments. Ã P , 0.05; ÃÃ P , 0.01 compared with fertilized counterparts. fE-3.5, fertilized embryos at day 3.5; pE-3.5, parthenogenetic embryos at day 3.5; fES, fertilized embryonic stem cells at passages 10; pES, parthenogenetic embryonic stem cells at passages 10; fES-TEC-9.5, fES cell-fetuses at day 9.5 supported by TEC; pE-9.5, parthenogenetic embryonic fetuses at day 9.5; pES-TEC-9.5, pES cell-fetuses at day 9.5 supported by TEC.
parthenogenetic fetuses and pES cell -fetuses supported by TEC (Fig. 2C) .
Bisulfite sequencing analysis confirmed that the DMRs of Igf2/H19 and Dlk1/Gtl2 were hypomethylated, and did not show obvious differences among pE, pES cells and pES cell -fetuses supported by TEC, which all maintained the methylation status of maternal alleles, in contrast to the balanced methylation levels of fertilized blastocysts, fES cells and fES cell -fetuses supported by TEC (Fig. 3) . Notably, the methylation status in the DMRs of Snrpn and Peg1 changed such that the hypermethylation in pE clearly was reversed in pES cells and pES cell -fetuses supported by TEC, and the methylation levels of Snrpn and Peg1 in pES cells resembled those of fES cells (Fig. 3) . In contrast, the DMRs remained hypermethylated in parthenogenetic embryonic fetuses at day 9.5. Together, these data show that expression and methylation of the paternally expressed imprinted genes, Snrpn, Peg1 and particularly U2af1-rs1, were remarkably reprogrammed during isolation and culture of pES cells.
Hypermethylation in pE and hypomethylation in PES cells may underlie reactivation of imprinted genes in PES cells
We assessed global methylation of early cleavage stage embryos and blastocysts derived from fertilization and parthenogenesis using the specific antibody anti-5-methylcytosine (5-MeC) and immunofluorescence microscopy. Also, methylation of fES cells and pES cells were analyzed by 5-MeC labeling and flow cytometry using IgG1 as a parallel control. At the one-cell stage, methylation did not differ between fertilized and pE ( Fig. 4A and C) . At the two-cell stage, methylation in pE slightly increased compared with fE. From the four-cell to blastocyst stage, pE showed remarkably higher methylation than did fE ( Fig. 4A and C) . In contrast, methylation of pES cells was significantly reduced compared with fES cells (Fig. 4B and C) . Coincidently, expression of DNA methyltransferases (Dnmt3a, Dnmt3b) was significantly reduced in pES cells compared with that of fES cells at similar passages (Supplementary Material, Fig. S2 ). Methylation of DMRs (Igf2/H19 ICR, Dlk1/Gtl2 IG-DMR, Snrpn DMR1 and Peg1 promoter and exon 1) in fertilized and parthenogenetic blastocysts, ES cells and embryonic fetuses. Genomic DNA from blastocysts, ES cells and embryonic fetuses was treated with bisulfite, followed by PCR amplification and sequencing. Shown are cytosines for a number of independently sequenced templates (horizontal lines). Individual lines, clones sequenced; circles, CpG sites within the regions analyzed; filled circles, methylated cytosines indicated by percentages underneath; open circles, unmethylated cytosines. fE-3.5, fertilized embryos at day 3.5; pE-3.5, parthenogenetic embryos at day 3.5; fES, fertilized embryonic stem cells at passages 10; pES, parthenogenetic embryonic stem cells at passages 10; TEC, tetraploid embryo complementation; fES-TEC-9.5, fES cell -fetuses at day 9.5 complemented by TEC; pE-9.5, parthenogenetic embryonic fetuses at day 9.5; pES-TEC-9.5: pES cell-fetuses at day 9.5 complemented by TEC.
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Epigenetic reprogramming may be associated with global demethylation, which coincides with reactivation of paternally expressed imprinted genes in pES cells.
Pluripotency in vivo of PES cells is highly correlated with epigenetic reprogramming of imprinted genes
Like fES cells, pES cells generated chimeras ( Fig. 5A ) with high efficiency (50%). Microsatellite analysis showed that the contribution from pES cells to tissues or organs (brain, skin, lung, muscle, heart, liver, spleen, kidney and intestine) in chimeras (Fig. 5B) increased from early to mid-passages, followed by decreased efficiency at late passages (Fig. 5C ). Consistently, expression of imprinted genes also changed in pES cells from early (p5), mid (p21) to late (p54) passage during long-term culture in vitro. Maternally expressed imprinted genes (H19 and Gtl2) and paternally expressed imprinted genes (Dlk1, Snrpn, Peg1 and U2af1-rs1) exhibited increased expression from early to mid-passages, followed by reduced expression at late passages. The maternally expressed imprinted gene Igf2r showed reduced expression at midpassages, but increased expression at late passages (Fig. 6A) . Methylation of imprinted genes also was unstable in pES cells during in vitro culture. Methylation levels of the DMRs for Igf2/H19 and Dlk1/Gtl2 increased at late passages, whereas methylation of the DMRs for Igf2r, Snrpn, Peg1 and U2af1-rs1 was high at early passages, reduced at midpassages and then increased again at late passages (Fig. 6B) . Notably, methylation of the DMRs for Igf2/H19 and Dlk1/ Gtl2 did not correlate with the expression levels of these genes (Fig. 6C) . In contrast, methylation of the DMRs for Igf2r, Snrpn, Peg1 and U2af1-rs1 highly correlated with their expression levels. Increased expression of Snrpn, Peg1 and U2af1-rs1 correlated with their decreased methylation; however, increased expression of Igf2r correlated with its increased methylation (Fig. 6D) .
Interestingly, we found a clear correlation between the methylation of imprinted genes with the contribution of pES cells in chimeras. Methylation of the DMRs for Igf2r and Snrpn and particularly U2af1-rs1 was highly negatively correlated with the contribution rate of pES cells to the chimeras (Fig. 7A, B and D) (Supplementary Material, Table S4 ). However, the DMRs for Igf2/H19 and Dlk1/Gtl2 showed hypomethylation with only limited changes, resulting in no or low relation to the contribution of pES cells to the chimeras (Fig. 7E and F) . Reduced methylation and increased expression of Snrpn and U2af1-rs1 might be important for development and differentiation of pES cells in vivo. Decreased expression of the maternally expressed gene Igf2r was associated with decreased methylation but increased contribution of pES cells to chimeras, suggesting that decreased expression of some maternally expressed imprinted genes also may be required for pluripotency of pES cells.
DISCUSSION
We show that methylation and expression of individual imprinted genes are reprogrammed during in vitro isolation and culture of pES cell lines from oocytes activated by strontium, followed by embryo culture in optimized medium KSOM AA . Coincidently, global demethylation occurs during isolation and culture of pES cells from early embryos. Further, decreased methylation of U2af1-rs1, Snrpn and Igf2r highly correlates with pluripotency of pES cells, as evidenced by high contributions of pES cells to chimeras.
Our data demonstrate that in vitro isolation and culture conditions can lower maternal methylation imprints, facilitate the expression of paternally expressed imprinted genes and maintain the expression of maternally expressed imprinted genes in pES cells. PES cells derived from pE expressed all paternally expressed imprinted genes examined, resembling fES cells. Further, Snrpn, Peg1 and U2af1-rs1 in pES cell -fetuses supported by TEC were not merely activated, and their expression levels were similar to those of fES cell -fetuses supported by TEC. Microsatellite analysis showed that pES cells but not TEC components contributed to pES cell -fetuses supported by TEC (Supplementary Material, Fig. S1 ). Loss of genomic imprinting occurs with the Peg1 and Snrpn genes in pES cell lines (39) , but the mechanisms underlying activation of paternally expressed imprinted genes remain unclear. We show that the activation of paternally expressed imprinted genes coincided with global demethylation during isolation and culture of pES cells from early embryos. Specifically, the DMRs for Snrpn, Peg1 and U2af1-rs1 became demethylated as global methylation decreased during in vitro culture, correlated with reactivation of these paternally expressed imprinted genes. These observations are compatible with the notion that global demethylation of DMRs by in vitro culture likely regulates the expression of parentally expressed imprinted genes (40) .
Normal embryogenesis requires contributions from both maternal and paternal genomes. Production of normal chimeras from pES cells depends on appropriate expression of imprinted genes. The contribution to chimeras of new pES cell lines at appropriate passages (e.g. at mid-passages) reported here was found in all tissues tested and did not exhibit tissue-specific distribution. Previous work showed selection against parthenogenetic cells in tissues of mesodermal and endodermal origin (e.g. skeletal muscle and liver) during embryogenesis (18, 41) , which might also be related to passage numbers. Repressed expression of Igf2 was associated with reduced contributions from pES cells to muscle (18, 41) . In our pES cell lines at passage 10, expression of Igf2 was similar to that in fES cells (Fig. 2B) . The pES cells at earlier passage (P5) also exhibited limited reprogramming of imprinted genes ( Fig. 6A and B) , in association with lower contributions of pES cells at passage 5 to chimeras than that at passage 21 (Fig. 5C) . The contribution to chimeras Ã P , 0.05; ÃÃ P , 0.01 (p21 versus p5 or p54 versus p21).
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Human Molecular Genetics, 2009, Vol. 18, No. 12 from these pES cells increased at mid-passages and greatly exceeded that reported previously from pES cells at early passages (P5 -7) (18, 41) . These data suggest that processes of reprogramming of imprinted genes for pluripotency of pES cells take place in a gradual fashion. Moreover, our pES cell lines were derived from oocytes fully activated by Sr 2þ and pE cultured in optimized medium KSOM AA , which show many similarities to fE (36) . Thus, several factors, including methods for oocyte activation, embryo culture media, prolongation of ICM outgrowth and in vitro culture and increased passage number at appropriate stages in combination, facilitate reprogramming of imprinted genes for pluripotency of pES cell lines.
Persistent hypomethylation of maternal imprints may not benefit pES cells, particularly when they remain undifferentiated in culture for prolonged periods. Continued long-term culture decreased the contribution of pES cells at late passages to chimeras, which could result from loss of X chromosomes and recovery of methylation (40) , and re-silencing of paternally expressed imprinted genes. The epigenetic state of ES cells also tends to be altered by long-term in vitro culture, which could negatively affect their pluripotency and genetic stability (42, 43) . These data suggest that optimal culture conditions are also required for improving long-term culture of pES cells, and like fES cells.
Interestingly, two paternally expressed imprinted genes, Igf2 and Dlk1, which had been activated both in parthenogenetic blastocysts and in derived pES cells, were inactivated in parthenogenetic embryonic fetuses and pES cell -fetuses supported by TEC. This likely suggests that Igf2 and Dlk1 are critical for fetal development. Indeed, deletion of the DMRs for Igf2/H19 and Dlk1/Gtl2 leads to the activation of these genes, accompanied by efficient production of live parthenogenetic offspring with germline transmission (44) . Yet, the DMRs of Igf2/H19 and Dlk1/Gtl2 exhibited extremely low levels of methylation in parthenotes, regardless of developmental stage, i.e. early embryos, mid-gestation fetuses, pES cells or pES cell -fetuses supported by TEC, although pES cell -fetuses supported by TEC showed relatively increased methylation in the DMRs of Igf2/H19 (Fig. 3) . Thus, methylation of DMRs did not correlate with activation and expression of these two genes (Figs 1, 2 and 6C) , suggesting that other mechanisms may also regulate their expression. Allele-specific histone acetylation is found to involve in regulating the expression of the Dlk1 -Gtl2 imprinted domain (45) , and regulation of the DMRs of Igf2/H19 and Dlk1/Gtl2 may share these common features (46, 47) .
Methylation status in the DMRs of Igf2r, Snrpn, Peg1 and U2af1-rs1 highly correlates with development and differentiation in vivo of pES cells to chimeras. Decreased methylation of paternally expressed imprinted genes, Snrpn, Peg1 and particularly U2af1-rs1, correlated with their increased expression, which may contribute to the high pluripotency of pES cells. These genes play important roles in embryonic development and some diseases. Mice with deletion of Snrpn show abnormal neuronal development, e.g. Prader -Willi syndrome (48) . Peg1-deficient females show abnormal maternal behavior and impaired placentophagia (49) . Mice with deletion of a 200 bp region termed region II of U2af1-rs1 are phenotypically normal, because the deleted allele does not change the methylation of this gene, and their parental function persists (50) . U2af1-rs1 encodes a putative 51 kDa protein, an essential mammalian splicing factor located on mouse chromosome 11, and maternal duplication/paternal deficiency results in a small body size (51), suggesting that U2af1-rs1 may be required for normal body size.
Activation of only paternally expressed imprinted genes, however, may not be sufficient to ensure high contributions of pES cells to chimeras. The maternally expressed imprinted gene Igf2r showed lower expression as its methylation decreased, correlating with higher contributions of pES cells to chimeras. Artificial reduction of Igf2r expression rescues the growth inhibition of parthenogenetic cells (52) . We suggest that decreased expression of some maternally expressed imprinted genes also is required to achieve pluripotency of pES cells. PES cell lines, which lose maternal methylation imprints and acquire more normal imprinting patterns and high pluripotency, provide a valuable model for studying epigenetic regulation of imprinting in mammalian development, and also have implications for the application of pES cells to stem cell therapy in regenerative medicine.
MATERIALS AND METHODS
pES cells
Unless otherwise specified, all reagents were obtained from Sigma Chemical Co. In vivo ovulated mature oocytes or immature oocytes collected from ovaries were used for derivation of pES cell lines. Hybrid B6C3F1 (C57BL/6xC3H) female mice (6 -8 weeks old) were superovulated by consecutive injections of 5 IU pregnant mare serum gonadotrophin (PMSG, Calbiochem) and human chorionic gonadotrophin (hCG) 44-48 h apart. fE were collected from females with (33, 34) . Immature oocytes at GV stage were collected by puncturing follicles in 20 mM HEPES-buffered in vitro maturation (IVM) medium 42-46 h after injection of PMSG and then cultured in 100 ml droplets of IVM medium covered with mineral oil at 378C in an atmosphere of 6.5% CO 2 in humidified air for 15-16 h. IVM medium consisted of 95% minimum essential medium (MEM, Invitrogen), 5% fetal bovine serum (FBS, Hyclone), 0.24 mM sodium pyruvate, 1.5 IU/ml hCG and 1 IU/ml PMSG.
Blastocysts were transferred onto feeder layers of mitomycin C-treated MEF, prepared on 0.1% gelatin treated four-well culture dishes, cultured in ES cell medium consisting of Knockout DMEM (GIBCO) and 20% KSR (Invitrogen), supplemented with 1000 U/ml mouse ESGRO leukemia inhibitory factor (Chemicon), 0.1 mM NEAA, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol, 50 IU/ml penicillin, 50 IU/ml streptomycin and 50 mM MAP Kinase inhibitor PD98059 (Cell Signaling) following standard procedures. ICM outgrowths were extended to 7 -10 days, harvested and passaged by pipetting following brief digestion with 0.25% trypsin -ETDA, and plated onto new feeder cells in ES cell medium without PD98059. Clones resembling ES cells in morphology were then picked, passaged and cultured in ES cell medium supplemented with FBS. For storage, ES cell lines were kept in freezing medium consisting of 40% ES cell medium without KSR, 50% FBS and 10% DMSO, and stored frozen in liquid nitrogen.
Chimeric mice, tetraploid embryo complementation and parthenogenetic embryonic fetuses
Blastocyst injection was performed by Piezo micromanipulation as described previously (53) . Briefly, fE were collected at day 3 post-coitum (dpc) from albino (ICR or Balb/c) females after mating. Ten to fifteen ES cells were injected into each blastocyst, and injected blastocysts were transferred into 2.5-dpc pseudopregnant females. Chimeric offspring were delivered naturally and examined for coat color, contribution of pES cells to chimeras by microsatellite analysis, and germline transmission.
For complementation with tetraploid (4n) embryos as a host, TEC were produced by electrofusion of two-cell embryos using an Eppendorf Multiporator, and then cultured in KSOM AA for two more days. About 20 ES cells were injected into tetraploid blastocysts, which were then transferred into 2.5-dpc pseudopregnant females.
Developed parthenogenetic blastocysts as controls were transferred into uterine horns of 2.5-dpc pseudopregnant females, and fetuses were recovered at day 9.5 of gestation. Parthenogenetic fetuses that had more than 15 somites and possessed heartbeat were selected for DNA/RNA extraction. 
DNA and cDNA preparation
Genomic DNA or total RNA was extracted from oocytes and embryos using DNA Micro Kit or RNA Micro Kit, and from ES cells, embryonic fetuses and adult tissues using DNA/ RNA Tissue Kit (Qiagen) according to the manufacturer's instructions.
RT -PCR and real-time PCR
Extracted RNA was subjected to cDNA synthesis using QuantiTect Reserve Transcription (Qiagen). Thermal cycling was carried out with a 10 min denaturation step at 948C, followed by 40 three-step cycles (30 s at 948C, 30 s at 58-638C and 30 s at 728C), with a final incubation at 728C for 10 min. RT -PCR products were separated on a 2% agarose gel, stained with ethidium bromide, visualized and photographed by Molecular Image Gel Doc XR System (Bio-Rad). The primer sequences for RT -PCR are detailed in Supplementary Material, Table S1 .
For real-time PCR, b-actin was used as a reference control and corrected for PCR efficiency in differences between target and reference with efficiency correction using Relative Quantification Software (Roche LC 480). Standard curves were made for each gene using known quantities of total cDNA from other cells. Thermal cycling was carried out with a 10 min denaturation step at 948C, followed by 40 three-step cycles: 30 s at 948C, 30 s at 608C and 30 s at 728C. Real-time PCR primers are detailed in Supplementary Material, Table S2 .
Bisulfite sequencing and COBRA Bisulfite treatment of DNA was performed with the EpiTect Bisulfite Kit (Qiagen). The bisulfite converted DNA was amplified by nested (semi-nested) PCR using HotStarTaq DNA Polymerase (Qiagen). Primer sequences are detailed in Supplementary Material, Table S3 . The outside primer pairs were used for the first-round PCR, whereas the inside primer pairs were used for the second-round PCR. Thermal cycling was carried out with a 10 min denaturation step at 948C, followed by 30-40 three-step cycles (30 s at 948C, 30 s at 55-588C and 30 s at 728C), and final incubation at 728C for 10 min. For the second-round PCR, 1 ml of the first-round sample was used and the conditions for the PCR were the same as above. PCR products were recovered from stained gels (QIAquick Gel Extraction Kit, Qiagen), cloned into a pGEM-T Easy vector (Promega), and then sequenced using T7 or SP6 primers with an ABI 3730 capillary genetic analyzer (Applied Biosystems) by BigDye terminator sequencing chemistry. Bisulfite efficiency as the fraction of modified cytosines in non-CpG sequences exceeded 98%.
For COBRA, 100 ng of the same purified PCR products used for sequence analysis was digested with appropriate restriction enzymes from New England Biolabs Inc. Cleavage occurs only if the cytosine residues remain methylated during the bisulfite conversion. The unmethylated product appeared as a single band, but the methylated product was cut into two bands by restriction enzymes. The percentage of fully methylated sites in a genomic DNA sample was calculated from the ratio between cleaved and total PCR products (55) . Methylation levels at specific sequence were obtained through analysis by Quantity One software (Bio-Rad) and by comparison with unmethylated fragments as negative controls.
Statistical analysis
The data were analyzed by SPSS13.0 analysis with t-test or ANOVA. P-value of , 0.05 was considered to be statistically significant.
